Modelling cell death in human tumour cell lines exposed to the anticancer drug paclitaxel

Abstract.Most anti-cancer drugs in use today exert their effects by inducing a programmed cell death mechanism. This process, termed apoptosis, is accompanied by degradation of the DNA and produces cells with a range of DNA contents. We have previously developed a phase transition mathematical model to describe the mammalian cell division cycle in terms of cell cycle phases and the transition rates between these phases. We now extend this model here to incorporate a transition to a programmed cell death phase whereby cellular DNA is progressively degraded with time. We have utilised the technique of flow cytometry to analyse the behaviour of a melanoma cell line (NZM13) that was exposed to paclitaxel, a drug used frequently in the treatment of cancer. The flow cytometry profiles included a complex mixture of living cells whose DNA content was increasing with time and dying cells whose DNA content was decreasing with time. Application of the mathematical model enabled estimation of the rate constant for entry of mitotic cells into apoptosis (0.035 per hour) and the duration of the period of DNA degradation (51 hours). These results provide a dynamic model of the action of an anticancer drug that can be extended to improve the clinical outcome in individual cancer patients.

[1]  I. Stakgold Green's Functions and Boundary Value Problems , 1979 .

[2]  X. Meng,et al.  Caspase-3 activates endo-exonuclease: Further evidence for a role of the nuclease in apoptosis , 2000, Apoptosis.

[3]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[4]  L. Delves,et al.  Numerical solution of integral equations , 1975 .

[5]  Graeme Wake,et al.  A mathematical model for analysis of the cell cycle in cell lines derived from human tumors , 2003, Journal of mathematical biology.

[6]  B. Lord,et al.  Growth Kinetics of Tumours , 1978, British Journal of Cancer.

[7]  W. B. Derry,et al.  Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. , 1996, Cancer research.

[8]  J. Tschopp,et al.  Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). , 1993, The EMBO journal.

[9]  I. N. Sneddon,et al.  Boundary value problems , 2007 .

[10]  V. Hutson Integral Equations , 1967, Nature.

[11]  M Takahashi,et al.  Theoretical basis for cell cycle analysis: II. Further studies on labelled mitosis wave method. , 1968, Journal of theoretical biology.

[12]  P. Morse,et al.  Methods of theoretical physics , 1955 .

[13]  A. Gudkov,et al.  The role of p53 in determining sensitivity to radiotherapy , 2003, Nature Reviews Cancer.

[14]  B. Baguley,et al.  Short-term cultures of clinical tumor material: potential contributions to oncology research. , 1999, Oncology research.

[15]  W. Telford,et al.  Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. , 1992, Cytometry.

[16]  O. Diekmann,et al.  The Dynamics of Physiologically Structured Populations , 1986 .